Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BIC/FTC/TAF”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 0 results

Not applicableNot Yet RecruitingNCT07620652
What this trial is testing

Pilot Study to Evaluate Efficacy and Safety of Switching to BIC/FTC/TAF in PWH With a Previous Virological Failure Under CAB/RPV LAI

Who this might be right for
HIV Infection
Cristina Mussini 30
Not applicableNot Yet RecruitingNCT07122557
What this trial is testing

Real World Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide(BIC/FTC/TAF) in PLWH in Precarity Settings in France -IMEA073

Who this might be right for
HIV-1Public Universal Healthcare Insurance CoverageBIC/FTC/TAF+1 more
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 320
Not applicableStudy completedNCT06829082
What this trial is testing

Real-Life Outcomes of TAF/FTC/BIC in HIV Patients in Colombia

Who this might be right for
HIV Treatment
Servicios de Salud IPS Suramericana S.A.S 161
Large-scale testing (Phase 3)Study completedNCT04223791
What this trial is testing

Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 643